Gybels et al., 1988 - Google Patents
Intrathecal programmed infusion of Baclofen in spasticityGybels et al., 1988
- Document ID
- 14437649061123181147
- Author
- Gybels J
- De Sutter P
- Weinmann P
- Publication year
- Publication venue
- Clinical Neurology and Neurosurgery
External Links
- 208000008238 Muscle Spasticity 0 title abstract description 8
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rudge et al. | Encephalomyelitis in primary hypogammaglobulinaemia | |
Lance et al. | A physiological approach to clinical neurology | |
Johnson et al. | Central nervous system manifestations of chickenpox | |
TWI233806B (en) | Pharmaceutical composition for treating diabetes by local administration | |
DE69837324T2 (en) | TREATMENT OF MULTIPLE SCLEROSIS BY USING COPOLYMER-1 | |
Dubin et al. | Acute hemorrhagic edema of childhood: an unusual variant of leukocytoclastic vasculitis | |
CN108271354A (en) | Composition comprising bacterium bacterial strain | |
CN102458476B (en) | Compositions and methods for treatment of multiple sclerosis | |
Albanese et al. | Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients. | |
Christ et al. | The application of gene therapy to the treatment of erectile dysfunction | |
ZIEGLER | Acute disseminated encephalitis: Some therapeutic and diagnostic considerations | |
Whiteside | A controlled study of benzydamine oral rinse (‘Difflam’) in general practice | |
Thrush et al. | How benign a symptom is facial numbness? | |
Bhat et al. | Intravenous daclizumab for recalcitrant ocular inflammatory disease | |
Solomon et al. | The use of sodoku in the treatment of general paralysis: a preliminary report | |
Gybels et al. | Intrathecal programmed infusion of Baclofen in spasticity | |
Duncan et al. | Methylprednisolone therapy in tropical spastic paraparesis. | |
Lask | Treatment of Vomiting of Pregnancy with Antihistamines | |
Goin et al. | Pauci-symptomatic foodborne botulism due to Clostridium botulinum type B with predominant ophthalmologic presentation possibly after consumption of honey | |
Fellman | Facial diplegia following ethylene glycol ingestion | |
Arteaga-Pérez et al. | Multiple dose toxicity study of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 intravenously administered to Cercopithecus aethiops sabaeus monkeys | |
Gadoth et al. | Permanent tetraplegia as a consequence of tetanus neonatorum: Evidence for widespread lower motor neuron damage | |
AU611961B2 (en) | Pharmaceutical preparation for curing multiple sclerosis and lateral amyotrophic sclerosis | |
CN106539815A (en) | Application of the ring dinucleotide in preventing and treating multiple sclerosis | |
Maddison | Neuromyotonia |